Relevance and importance of the conference
The modernization of the pharmaceutical industry is a major priority of Russia's domestic policy. Reducing the share of imported and increasing the share of domestic medicines are strategically important tasks in the regulation of the pharmaceutical market. The localization of pharmaceutical manufacturing in Russia is one of the ways to achieve these objectives.
Despite difficult political and economic circumstances, representatives of foreign pharmaceutical businesses still highly appreciate the prospects and potential of the Russian pharmaceutical market. Moreover, they are actively planning for the further development of their companies in all of Russia's regions.
One of the goals of the conference is to encourage the establishment of a meaningful dialogue between the public and private sectors on the localization of pharmaceutical facilities in Russia, as well as financing for infrastructure projects and the involvement of foreign investors. It also aims to promote the exchange of experience between members of the business community, and help find solutions to modern problems in the industry.
Key topics to be discussed
- Development of local production facilities: the current situation and future prospects. Financial and other support provided by the state to companies that build pharmaceutical facilities in Russia.
- Business planning in the Russian Federation: building your own plant or contract manufacturing? How to find and hold a niche in a constantly growing market?
- Specificities of public procurement in the healthcare sector. Three-stage structure: to be or not to be?
- Modernization of the pharmaceutical industry: development of innovative pharmaceutical production in Russia.
- Clusterization and manufacture location. Industrial parks and special economic zones. The best pharmaceutical production practices in the regions of Russia.
- Technology transfer localization prospects.
- Construction of pharmaceutical facilities with minimal risk.
The conference's target audience includes the Russian and foreign business community with a stake in doing business in the regions of the Russian Federation. Registration is now open for chief executives and managers in pharmaceutical companies, the chemical industry, logistic operators, special economic zone and industrial park representatives, as well as leading consulting companies and legal firms.
Participating industries
- Pharmaceutical industry
- Chemical industry
- Pharmacy chains and distributors
- Transport and logistics
- Development and construction
- Industrial parks
- Special economic zones
Positions of the participants
- CEO / General Director / President
- Business Development Director / Commercial Director
- Production Director
- Logistics Director
- Director for Access to Medicine, Corporate Relations, Relations with Public Authorities
- Chief Operating Officer, Marketing and Sales Director
- Chief Legal Officer, Procurement Director
PROGRAM09:30 – 10:00 Participant registration. Coffee
10:00 – 12:00 Plenary session.
Localization of medicines' production as a driver for import substitution processes in the pharmaceutical industry Moderator
Lilia Titova, Executive Director, Union of Professional Pharmaceutical Organizations
Topics for discussion
- Development of local production facilities: barriers and prospects.
- Financial and other support provided by the state to companies that build pharmaceutical facilities in Russia.
- Specificities of public procurement in the healthcare sector. Three-stage structure: to be or not to be?
- Business planning in the Russian Federation: building your own plant or contract manufacturing? How to find and hold a niche in a constantly growing market?
- The prospects of improvement in Russian jurisdiction to make localization more attractive to foreign companies.
- Clusterization and manufacture location. Industrial parks and special economic zones. The system of benefits and preferential advantages.
Speakers
Aleksey Alekhin, Head of Department of Pharmaceutical and Medical Industry Development, Ministry of Industry and Trade of the Russian Federation
Ivan Glushkov, Deputy Director General, Stada CIS
Maria Kobanenko, Counsel, «Egorov Puginsky Afanasiev & Partners» law firm
Oleg Korzinov, Executive Director, Biopharmaceutical cluster «Northern»
Irina Saadueva, Head of Legal Department, Schneider Group Moscow
Kristina Volkonitskaya, Acting Director, Agency of industrial development of Moscow
Vadim Yatsuk, СEO, «Sotex» Pharm Firm»
12:00 – 12:30 Coffee break
12:30 – 14:30 Expert panel.
Modernization of the pharmaceutical industry. Development of innovative pharmaceutical production in Russia Moderator
Alexander Kuzin, Managing Director, «NovaMedica»
Topics for discussion
- Development of innovative pharmaceutical production in Russia: the current situation and development prospects.
- Instruments and measures of state support for innovative pharmaceutical companies.
- Prospects for the localization of technology transfer.
- Copyright and competition promotion: is the balance achievable?
Speakers
Elena Arkhangelskaya, President, «NPO Petrovax Pharm»
Alexey Abramov, Managing Partner, Russian Intellectual Property Agency «Gardium»
Elena Bushberg, CEO, «Veropharm»
Grigory Ivliev, Head, Federal Service for Intellectual Property (Rospatent)
14:30 – 15:30 Lunch break
